Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study

BACKGROUND/AIMS: To evaluate efficacy and safety of intravitreal aflibercept (IVT-AFL) in Japanese patients with wet age-related macular degeneration (wAMD) from the VIEW 2 trial. METHODS: In this double-masked study, patients were randomised to: 0.5 mg IVT-AFL every 4 weeks (0.5q4); 2 mg IVT-AFL ev...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Br J Ophthalmol
Autori principali: Ogura, Yuichiro, Terasaki, Hiroko, Gomi, Fumi, Yuzawa, Mitsuko, Iida, Tomohiro, Honda, Miki, Nishijo, Koichi, Sowade, Olaf, Komori, Tetsushi, Schmidt-Erfurth, Ursula, Simader, Christian, Chong, Victor
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2015
Soggetti:
Clinical Science
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4283691/
https://ncbi.nlm.nih.gov/pubmed/25107900
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2014-305076
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi